190 related articles for article (PubMed ID: 8905327)
1. Cannabinoid modulation of rat pup ultrasonic vocalizations.
McGregor IS; Dastur FN; McLellan RA; Brown RE
Eur J Pharmacol; 1996 Oct; 313(1-2):43-9. PubMed ID: 8905327
[TBL] [Abstract][Full Text] [Related]
2. Effects of cannabinoid receptor stimulation and blockade on catalepsy produced by dopamine receptor antagonists.
Anderson JJ; Kask AM; Chase TN
Eur J Pharmacol; 1996 Jan; 295(2-3):163-8. PubMed ID: 8720580
[TBL] [Abstract][Full Text] [Related]
3. Increased motivation for beer in rats following administration of a cannabinoid CB1 receptor agonist.
Gallate JE; Saharov T; Mallet PE; McGregor IS
Eur J Pharmacol; 1999 Apr; 370(3):233-40. PubMed ID: 10334497
[TBL] [Abstract][Full Text] [Related]
4. Differences in the relative potency of SR 141716A and AM 251 as antagonists of various in vivo effects of cannabinoid agonists in C57BL/6J mice.
McMahon LR; Koek W
Eur J Pharmacol; 2007 Aug; 569(1-2):70-6. PubMed ID: 17553486
[TBL] [Abstract][Full Text] [Related]
5. Pre-exposure to the cannabinoid receptor agonist CP 55940 enhances morphine behavioral sensitization and alters morphine self-administration in Lewis rats.
Norwood CS; Cornish JL; Mallet PE; McGregor IS
Eur J Pharmacol; 2003 Mar; 465(1-2):105-14. PubMed ID: 12650839
[TBL] [Abstract][Full Text] [Related]
6. Examination of the effect of the cannabinoid receptor agonist, CP 55,940, on electrically evoked transmitter release from rat brain slices.
Gifford AN; Samiian L; Gatley SJ; Ashby CR
Eur J Pharmacol; 1997 Apr; 324(2-3):187-92. PubMed ID: 9145770
[TBL] [Abstract][Full Text] [Related]
7. Influence of cannabinoids on electrically evoked dopamine release and cyclic AMP generation in the rat striatum.
Cadogan AK; Alexander SP; Boyd EA; Kendall DA
J Neurochem; 1997 Sep; 69(3):1131-7. PubMed ID: 9282935
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic modulation of rat pup ultrasonic vocalizations.
Dastur FN; McGregor IS; Brown RE
Eur J Pharmacol; 1999 Oct; 382(2):53-67. PubMed ID: 10528139
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive, behavioural and neuroendocrine effects of CP 55,940 in young rats.
Romero EM; Fernández B; Sagredo O; Gomez N; Urigüen L; Guaza C; De Miguel R; Ramos JA; Viveros MP
Brain Res Dev Brain Res; 2002 Jun; 136(2):85-92. PubMed ID: 12101025
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hippocampal acetylcholine release by cannabinoids: reversal by SR 141716A.
Gessa GL; Mascia MS; Casu MA; Carta G
Eur J Pharmacol; 1997 May; 327(1):R1-2. PubMed ID: 9185841
[TBL] [Abstract][Full Text] [Related]
11. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system.
Braida D; Pozzi M; Cavallini R; Sala M
Neuroscience; 2001; 104(4):923-6. PubMed ID: 11457579
[TBL] [Abstract][Full Text] [Related]
12. Effects of the cannabinoid receptor agonist CP 55,940 and the cannabinoid receptor antagonist SR 141716 on intracranial self-stimulation in Lewis rats.
Arnold JC; Hunt GE; McGregor IS
Life Sci; 2001 Nov; 70(1):97-108. PubMed ID: 11764010
[TBL] [Abstract][Full Text] [Related]
13. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
[TBL] [Abstract][Full Text] [Related]
14. Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats.
Mendiguren A; Pineda J
Eur J Pharmacol; 2006 Mar; 534(1-3):83-8. PubMed ID: 16483566
[TBL] [Abstract][Full Text] [Related]
15. Integrity of extracellular loop 1 of the human cannabinoid receptor 1 is critical for high-affinity binding of the ligand CP 55,940 but not SR 141716A.
Murphy JW; Kendall DA
Biochem Pharmacol; 2003 May; 65(10):1623-31. PubMed ID: 12754098
[TBL] [Abstract][Full Text] [Related]
16. Reversal of SR 141716A-induced head-twitch and ear-scratch responses in mice by delta 9-THC and other cannabinoids.
Janoyan JJ; Crim JL; Darmani NA
Pharmacol Biochem Behav; 2002; 71(1-2):155-62. PubMed ID: 11812518
[TBL] [Abstract][Full Text] [Related]
17. Delta(9)-tetrahydrocannabinol and synthetic cannabinoids prevent emesis produced by the cannabinoid CB(1) receptor antagonist/inverse agonist SR 141716A.
Darmani NA
Neuropsychopharmacology; 2001 Feb; 24(2):198-203. PubMed ID: 11120402
[TBL] [Abstract][Full Text] [Related]
18. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: evidence for a "CB3" receptor.
Fride E; Foox A; Rosenberg E; Faigenboim M; Cohen V; Barda L; Blau H; Mechoulam R
Eur J Pharmacol; 2003 Feb; 461(1):27-34. PubMed ID: 12568912
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterisation of cannabinoid CB(1) receptors in the rat and mouse.
Lay L; Angus JA; Wright CE
Eur J Pharmacol; 2000 Mar; 391(1-2):151-61. PubMed ID: 10720647
[TBL] [Abstract][Full Text] [Related]
20. Local pressure application of cannabinoid agonists increases spontaneous activity of rat substantia nigra pars reticulata neurons without affecting response to iontophoretically-applied GABA.
Tersigni TJ; Rosenberg HC
Brain Res; 1996 Sep; 733(2):184-92. PubMed ID: 8891301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]